Ozcelik, UmitBircan, Huseyin YuceKarakayali, FezaMoray, GokhanDemirag, Alp2023-11-142023-11-1420151304-0855http://hdl.handle.net/11727/10850To minimize the recurrence of a previously treated neoplasm in organ recipients, a period of 2 to 5 years without recurrence is advocated for most malignancies. However, prostate cancer is different because of its biological properties, diagnosis, and treatment. Most prostate cancers are detected at a low stage and demonstrate slow growth after detection. Definitive treatment with radical prostatectomy affords excellent results. Renal transplant candidates with early-stage prostate cancer have a higher risk of dying on dialysis than dying from prostate cancer; therefore, renal transplant candidates with organ-confined prostate cancer should be immediately considered for transplant.enginfo:eu-repo/semantics/closedAccessNomogramProstate-specific antigenChronic renal failureDialysisArticle13Supplement 374760003788003000202-s2.0-84953867899